C4 Therapeutics (NasdaqGS:CCCC) FY Conference November 12, 2025 08:30 AM ET Speaker0Great. Thanks, everyone, for continuing to join us here at Guggenheim Securities' second annual Healthcare Innovation Conference. My name is Brad Cunino, Senior Analyst here. Very happy to do the next fireside chat with C4 Therapeutics. We've got Andrew Hirsch, President and CEO, Len Reyno, CMO. Thanks so much for joining us.Speaker2Thanks for having us.Speaker0It's been a busy year at C4. Maybe just introduce the company an ...

Pfizer (PFE), a pharmaceutical and biotechnology company, rose to great heights during the pandemic with its COVID-19 vaccine. However, it has spent the last few years attempting to reposition itself following the post-pandemic decline in COVID-related revenues. Many investors have written off the stock due to deteriorating sales of Comirnaty and Paxlovid, as well as concerns that its recovery strategies will fail to produce long-term growth. Pfizer stock has dipped 19.3% over the past 52 weeks and 9.7% ye ...